FROM THE NEW YORK TIMES: A BETTER ALTERNATIVE TO STATINS?

default image

  This story was in the headlines today. Merck finally got the results they were looking for on their drug Vytorin. Note that the drug did not lower plaque build-up and that all the subjects in the test were eating a low-fat / low-cholesterol diet. Vytorin (a combination of ezetimibe and a statin) showed a slight improvement over a statin alone, but it was not tested against a dietary change. Moral: give people (who already have coronary disease) a diet that causes inflammation and a drug…

Continue reading

CHOLESTEROL CLARITY

default image

Cholesterol got a bad rap. The evidence continues to accumulate that cholesterol is not the villain it is made out to be, but is actually part of your body’s defense system against the real killers: chronic inflammation, the lack of good, natural fats, and stress. Dr. Dwight Lundell, one of the 29 experts interviewed by author Jimmy Moore in Cholesterol Clarity, noted that in the absence of inflammation, “Cholesterol would move freely throughout the body as nature intended.” Mark Sisson, another contributor, said, “Cholesterol is one…

Continue reading

Huh?

default image

There was a two-page ad in this morning’s Seattle Times for Vytorin® (ezetimibe/simvastatin), which is a combination of two older drugs (Zocor and Zetia) for lowering cholesterol. The headline said, “Do you have high LDL cholesterol? It’s important to talk to your doctor about ways to lower it.” After a few sentences about how the drug works to lower cholesterol, it says in bold type, “Vytorin has not been shown to reduce heart attacks or strokes more than Zocor alone.” I did a double take…

Continue reading